Maryland Oncology Hematology, welcomes Mark W. Lamplugh Jr. as the Head of Marketing and Growth, with a proven track record of exceptional work experience. It is with confidence that Lamplugh would be an essential aspect to our executive team as the Head of Marketing and Growth with the medical group. Lamplugh comes with over 20-years of administrative experience with a portfolio demonstrating his expertise in Marketing, Social Media, Digital Marketing, Brand Development, and Public Relations that has effectively generated successful growth to several national companies. Effective marketing approaches are essential when it comes to coining the message of HOPE that Maryland Oncology Hematology (MOH) will provide for their patients.
“Communication is the key, and with Mark being an addition to the team, I’m sure, with his expertise, he will provide excellence.” ~ Joseph Haggerty, M.D., F.A.C.P
In addition to Mark’s credentials, he has written “Beginners Guide to Digital and Social Media Marketing” and “Marketing Playbook For Social Media”, which made it on the top 100 Social Media Marketing Books of All Time by Book Authority. Also, Mark is one of the Board of Directors at One World for Life, the National Fire Heritage Center, and Institue for Responder Wellness allowing them to utilize his skills in marketing, branding and public relations.
Cancer has had a significant impact on society in the United States and across the world. It is a disease that could be a death sentence or a survival story for many. The American Cancer Society has provided information that there will be a projected 1,806,950 new cancer cases and 606,520 cancer deaths for the 2020 year in the U.S. The highest incidence rates between 2012-2016 were breast cancer among women, and the highest death rate between 2013-2017 was from lung and bronchus cancer.
Maryland Oncology Hematology is dedicated to providing the most advanced cancer care available anywhere in an atmosphere of caring and compassion. MOH has eleven offices throughout the state of Maryland, and a dedicated team of physicians that are here to increase the cancer survivorship rate.
Maryland Oncology Hematology also participates in clinical trials through U.S. Oncology Research, which has helped to develop forty-three F.D.A. approved cancer therapies.
Seventy-seven thousand patients and one goal, Maryland Oncology Hematology, is dedicated to advancing cancer care by leading and participating in clinical trials that test the safety and efficiency of new or modified treatments. These trials help uncover new treatment options, and allow many patients to receive newly developed therapies or investigational drugs not yet available outside the study. MOH is united in healing along with the U.S Oncology Network, for those experiencing financial difficulty. With our public advocacy program, our patients are offered dedicated support to help access reimbursement assistance programs. Programs and clinical trials that are provided at MOH are a part of the progress that will effectively serve the people who need tailor-made treatments. The people who are financially burdened, in many cases, are statistically the ones that come to demise at a rapid rate due to a lack of early detection.
With Mark Lamplugh serving as our Head of Marketing and Growth, we are sure our marketing message will get to all Maryland communities we serve, as well as those in the surrounding D.C. and Virginia area.
For more information, please visit https://marylandoncology.com/
Company Name: Maryland Oncology Hematology
Contact Person: Mark Lamplugh, Head of Marketing & Growth
Email: Send Email
Address:11720 Beltsville Drive Suite 300
Country: United States